Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,272 | 6,034 | 5,414 | 10,865 | 7,151 |
| Depreciation Amortization | 29,474 | 109,654 | 80,535 | 49,508 | 23,943 |
| Income taxes - deferred | 601 | 1,138 | 2,193 | 1,241 | 100 |
| Accounts receivable | -2,653 | -1,175 | -7,560 | -8,376 | -7,993 |
| Other Working Capital | -12,819 | -1,757 | -5,230 | -7,047 | -2,429 |
| Other Operating Activity | 4,410 | 15,362 | 18,516 | 14,332 | 9,339 |
| Operating Cash Flow | $24,285 | $129,256 | $93,868 | $60,523 | $30,111 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28,835 | -185,174 | -124,537 | -100,344 | -33,129 |
| Net Acquisitions | N/A | -16,059 | -16,080 | -16,189 | -6,680 |
| Other Investing Activity | 4,114 | 19,633 | 17,368 | 11,778 | 7,073 |
| Investing Cash Flow | $-24,721 | $-181,600 | $-123,249 | $-104,755 | $-32,736 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 85,787 | 552,540 | 432,540 | 291,990 | 145,200 |
| Debt Repayment | -100,541 | -496,270 | -408,375 | -261,413 | -136,445 |
| Common Stock Issued | 327 | N/A | N/A | 0 | N/A |
| Common Stock Repurchased | N/A | -9,176 | -9,176 | -7,117 | -6,032 |
| Other Financing Activity | 0 | -1,515 | -696 | -431 | 245 |
| Financing Cash Flow | $-14,427 | $45,579 | $14,293 | $23,029 | $2,968 |
| Exchange Rate Effect | 997 | -674 | 1 | 276 | 206 |
| Beginning Cash Position | 52,326 | 59,765 | 52,553 | 52,553 | 52,553 |
| End Cash Position | 38,460 | 52,326 | 37,466 | 31,626 | 53,102 |
| Net Cash Flow | $-13,866 | $-7,439 | $-15,087 | $-20,927 | $549 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,285 | 129,256 | 93,868 | 60,523 | 30,111 |
| Capital Expenditure | -48,160 | -251,247 | -170,674 | -130,288 | -45,869 |
| Free Cash Flow | -23,875 | -121,991 | -76,806 | -69,765 | -15,758 |